Journal article
The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders
WJ Jeon, AS Gibbons, B Dean
Progress in Neuro Psychopharmacology and Biological Psychiatry | Published : 2013
Abstract
[3H]4-DAMP is a radioligand that has been used to quantify levels of the muscarinic receptor CHRM3 protein in situ. However, in addition to high affinity binding to CHRM3, [3H]4-DAMP binds with low affinity to CHRM1 confounding the potential to discriminate between changes in these two muscarinic receptors. We have developed a [3H]4-DAMP binding assay, optimised for measuring CHRM3 protein levels in the cortex, with minimal selectivity towards CHRM1. The selectivity of our assay towards CHRM3 was confirmed using recombinant receptor-expressing, cell lysate preparations. [3H]4-DAMP binding levels were similar between wildtype and CHRM1 knockout mice, confirming that the amount of [3H]4-DAMP b..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
Preparation of the CHO-K1 cells and post-mortem tissue was performed by Madhara Udawela and Geoffrey Pavey, respectively. Brian Dean is an NHMRC Senior Research Fellow. This work was supported in part by NHMRC project grant #628699 and the Victorian Government's Operational Infrastructure Support.